Breaking News Instant updates and real-time market news.

XPER

Xperi

$22.50

-0.25 (-1.10%)

09:01
01/23/18
01/23
09:01
01/23/18
09:01

Xperi partners with ARCloud to bring music recognition to hybrid ratio

Xperi Corporation and ACRCloud, a Beijing-based audio fingerprinting service provider, have announced a partnership to integrate ACRCloud music recognition technology into the DTS Connected Radio platform. Through this partnership, DTS, a wholly owned subsidiary of Xperi, will use ACRCloud's technology to identify the music playing on radio stations in vehicles around the world.

XPER Xperi
$22.50

-0.25 (-1.10%)

10/11/17
SIDC
10/11/17
NO CHANGE
Target $57
SIDC
Buy
Xperi setback 'minor' in German patent fight, says Sidoti
After Broadcom (AVGO) announced last night that the German Federal Patent Court issued a preliminary opinion that all claims of a patent asserted against Broadcom in Germany by Invensas, an affiliate of Xperi (XPER), should be null and void, Sidoti analyst Matthew Galinko argued the investor concern over the news is overblown. Galinko noted the German court's decision isn't final, adding that a final determination in the "more material" ITC case is due in December. The analyst, who views Xperi shares as undervalued, maintains a Buy rating and $57 price target on the stock, which is down 12.6% to $23 in early trading.
11/03/17
BOFA
11/03/17
DOWNGRADE
Target $26
BOFA
Neutral
Xperi downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Krish Sankar downgraded Xperi (XPER) to Neutral and cut its price target to $26 from $36 following the Q3 report and disappointing outlook. The analyst said fundamentals are weakening and the multiple could remain under pressure until the Broadcom (AVGO) legal case is resolved on December 1.
12/14/17
BNCH
12/14/17
NO CHANGE
BNCH
Buy
Xperi request to ITC may be signal of work on Broadcom license, says Benchmark
After Xperi's (XPER) Tessera division made a last minute request for the ITC to delay its release of its final determination in the company's patent complaint against Broadcom (AVGO), Benchmark analyst Gary Mobley said he thinks this may be related to an attempt to hash out a license agreement, perhaps at Broadcom's request. A license agreement would be a positive both because it would allow Xperi to achieve the high end of its Q4 revenue guidance but also because it could represent "the first domino to fall" with Samsung (SSNLF) and others, said Mobley, who keeps a Buy rating on Xperi shares.
12/18/17
CHLM
12/18/17
NO CHANGE
Target $40
CHLM
Buy
Xperi shares have room to rally further, says Craig-Hallum
Craig-Hallum analyst Richard Shannon believes Xperi's (XPER) settlement with Broadcom (AVGO) is "strong confirmation" of the company's process and intellectual property. Licensing Broadcom will drive other customers to license rather than litigate, Shannon tells investors in an intraday research note. He believes the upfront payment for Q4, which was not disclosed, is around $30M and that ongoing payments are likely extend around four years. Shannon sees a "multiplier effect" from the settlement and believes shares of Xperi have further room to run. The analyst has a Buy rating on the shares with a $40 price target. The stock in afternoon trading is up 9% to $25.78.

TODAY'S FREE FLY STORIES

ULH

Universal Logistics

$26.50

0.15 (0.57%)

08:01
06/19/18
06/19
08:01
06/19/18
08:01
Initiation
Universal Logistics initiated  »

Universal Logistics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

LSTR

Landstar System

$115.30

0.25 (0.22%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Initiation
Landstar System initiated  »

Landstar System resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$49.15

0.3 (0.61%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Recommendations
Mirati Therapeutics analyst commentary  »

Mirati Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

ECHO

Echo Global

$30.40

-0.15 (-0.49%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Initiation
Echo Global initiated  »

Echo Global resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

CHRW

C.H. Robinson

$90.67

0.57 (0.63%)

07:59
06/19/18
06/19
07:59
06/19/18
07:59
Initiation
C.H. Robinson initiated  »

C.H. Robinson resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

TTPH

Tetraphase

$4.20

-0.05 (-1.18%)

07:59
06/19/18
06/19
07:59
06/19/18
07:59
Conference/Events
Tetraphase has a conference call hosted by SunTrust »

SunTrust will host a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 25

    Jun

  • 28

    Aug

BTE

Baytex Energy

$3.40

-0.47 (-12.16%)

07:56
06/19/18
06/19
07:56
06/19/18
07:56
Upgrade
Baytex Energy rating change  »

Baytex Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$14.05

(0.00%)

07:56
06/19/18
06/19
07:56
06/19/18
07:56
Recommendations
Snap analyst commentary  »

Snap survey shows usage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:55
06/19/18
06/19
07:55
06/19/18
07:55
General news
U.S. chain store sales rose 1.4% in the week ended June 16 »

U.S. chain store sales…

HSGX

Histogenics

$2.87

-0.1 (-3.37%)

07:55
06/19/18
06/19
07:55
06/19/18
07:55
Conference/Events
Histogenics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

TDG

TransDigm

$340.12

0.06 (0.02%)

07:54
06/19/18
06/19
07:54
06/19/18
07:54
Recommendations
TransDigm analyst commentary  »

TransDigm poised to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MDGL

Madrigal Pharmaceuticals

$306.24

6.23 (2.08%)

, BMY

Bristol-Myers

$53.65

-1.155 (-2.11%)

07:54
06/19/18
06/19
07:54
06/19/18
07:54
Downgrade
Madrigal Pharmaceuticals, Bristol-Myers, Nektar rating change  »

Madrigal cut to In Line…

MDGL

Madrigal Pharmaceuticals

$306.24

6.23 (2.08%)

BMY

Bristol-Myers

$53.65

-1.155 (-2.11%)

NKTR

Nektar

$58.40

0.545 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 10

    Jul

RHT

Red Hat

$176.26

1.27 (0.73%)

07:53
06/19/18
06/19
07:53
06/19/18
07:53
Downgrade
Red Hat rating change  »

Red Hat downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

GLT

Glatfelter

$18.95

0.1 (0.53%)

07:49
06/19/18
06/19
07:49
06/19/18
07:49
Hot Stocks
Glatfelter to acquire Georgia-Pacific's European nonwovens business for $185M »

Glatfelter announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$176.50

-6.25 (-3.42%)

, CELG

Celgene

$77.71

-0.38 (-0.49%)

07:48
06/19/18
06/19
07:48
06/19/18
07:48
Upgrade
Bluebird Bio, Celgene rating change  »

Bluebird Bio upgraded to…

BLUE

Bluebird Bio

$176.50

-6.25 (-3.42%)

CELG

Celgene

$77.71

-0.38 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBSV

ObsEva

$17.21

2.68 (18.44%)

07:48
06/19/18
06/19
07:48
06/19/18
07:48
Recommendations
ObsEva analyst commentary  »

ObsEva price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

DLAKY

Lufthansa

$0.00

(0.00%)

, NWARF

Norwegian Air Shuttle

$0.00

(0.00%)

07:44
06/19/18
06/19
07:44
06/19/18
07:44
Periodicals
Norwegian Air says takeover bids go beyond Lufthansa, IAG, Bloomberg reports »

Norwegian Air Shuttle…

DLAKY

Lufthansa

$0.00

(0.00%)

NWARF

Norwegian Air Shuttle

$0.00

(0.00%)

ICAGY

IAG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$47.46

-0.59 (-1.23%)

, TMUS

T-Mobile

$60.37

0.37 (0.62%)

07:44
06/19/18
06/19
07:44
06/19/18
07:44
Upgrade
Verizon, T-Mobile, Sprint rating change  »

Deutsche sees 23% total…

VZ

Verizon

$47.46

-0.59 (-1.23%)

TMUS

T-Mobile

$60.37

0.37 (0.62%)

S

Sprint

$5.55

0.055 (1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

DPS

Dr Pepper Snapple

$121.77

0.32 (0.26%)

07:43
06/19/18
06/19
07:43
06/19/18
07:43
Downgrade
Dr Pepper Snapple rating change  »

Dr Pepper downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RUT

Russell 2000 Index

$0.00

(0.00%)

, IWM

iShares Trust Russell 2000 Index Fund

$168.59

0.89 (0.53%)

07:41
06/19/18
06/19
07:41
06/19/18
07:41
Technical Analysis
Technical Take: iShares Trust Russell 2000 Index Fund slips in pre-market »

The iShares Trust Russell…

RUT

Russell 2000 Index

$0.00

(0.00%)

IWM

iShares Trust Russell 2000 Index Fund

$168.59

0.89 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COBZ

CoBiz Financial

$21.89

-0.25 (-1.13%)

07:39
06/19/18
06/19
07:39
06/19/18
07:39
Downgrade
CoBiz Financial rating change  »

CoBiz Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLDR

Builders FirstSource

$18.87

(0.00%)

07:38
06/19/18
06/19
07:38
06/19/18
07:38
Conference/Events
Builders FirstSource management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

TNDM

TNDM

07:36
06/19/18
06/19
07:36
06/19/18
07:36
Conference/Events
Tandem Diabetes management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

PBCT

People's United

$18.74

0.02 (0.11%)

, FBNK

First Connecticut

$26.05

0.15 (0.58%)

07:35
06/19/18
06/19
07:35
06/19/18
07:35
Hot Stocks
People's United to acquire First Connecticut in $544M stock transaction »

People's United…

PBCT

People's United

$18.74

0.02 (0.11%)

FBNK

First Connecticut

$26.05

0.15 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNG

Cheniere Energy

$65.28

1.03 (1.60%)

, CQH

Cheniere Energy Partners LP

$30.33

0.29 (0.97%)

07:35
06/19/18
06/19
07:35
06/19/18
07:35
Hot Stocks
Cheniere Energy, Cheniere Energy Partners LP agree to definitive merger »

Cheniere Energy (LNG) and…

LNG

Cheniere Energy

$65.28

1.03 (1.60%)

CQH

Cheniere Energy Partners LP

$30.33

0.29 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.